132 related articles for article (PubMed ID: 20578023)
1. Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility-weighted MRI parameters in the benign and malignant human prostate.
Alonzi R; Taylor NJ; Stirling JJ; d'Arcy JA; Collins DJ; Saunders MI; Hoskin PJ; Padhani AR
J Magn Reson Imaging; 2010 Jul; 32(1):155-64. PubMed ID: 20578023
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
3. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer detection on dynamic contrast-enhanced MRI: computer-aided diagnosis versus single perfusion parameter maps.
Sung YS; Kwon HJ; Park BW; Cho G; Lee CK; Cho KS; Kim JK
AJR Am J Roentgenol; 2011 Nov; 197(5):1122-9. PubMed ID: 22021504
[TBL] [Abstract][Full Text] [Related]
5. Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: an in vivo human study using susceptibility and relaxivity dynamic MRI.
Alonzi R; Padhani AR; Taylor NJ; Collins DJ; D'Arcy JA; Stirling JJ; Saunders MI; Hoskin PJ
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):721-7. PubMed ID: 20630668
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
7. Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI.
Kiessling F; Lichy M; Grobholz R; Heilmann M; Farhan N; Michel MS; Trojan L; Ederle J; Abel U; Kauczor HU; Semmler W; Delorme S
Eur Radiol; 2004 Oct; 14(10):1793-801. PubMed ID: 15232714
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.
Hötker AM; Mazaheri Y; Zheng J; Moskowitz CS; Berkowitz J; Lantos JE; Pei X; Zelefsky MJ; Hricak H; Akin O
Eur Radiol; 2015 Sep; 25(9):2665-72. PubMed ID: 25820537
[TBL] [Abstract][Full Text] [Related]
9. Washout gradient in dynamic contrast-enhanced MRI is associated with tumor aggressiveness of prostate cancer.
Chen YJ; Chu WC; Pu YS; Chueh SC; Shun CT; Tseng WY
J Magn Reson Imaging; 2012 Oct; 36(4):912-9. PubMed ID: 22711415
[TBL] [Abstract][Full Text] [Related]
10. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.
Galbraith SM; Lodge MA; Taylor NJ; Rustin GJ; Bentzen S; Stirling JJ; Padhani AR
NMR Biomed; 2002 Apr; 15(2):132-42. PubMed ID: 11870909
[TBL] [Abstract][Full Text] [Related]
11. Enhancing fraction in glioma and its relationship to the tumoral vascular microenvironment: A dynamic contrast-enhanced MR imaging study.
Mills SJ; Soh C; O'Connor JP; Rose CJ; Buonaccorsi G; Cheung S; Zhao S; Parker GJ; Jackson A
AJNR Am J Neuroradiol; 2010 Apr; 31(4):726-31. PubMed ID: 20019100
[TBL] [Abstract][Full Text] [Related]
12. Correlation of quantitative diffusion-weighted and dynamic contrast-enhanced MRI parameters with prognostic factors in prostate cancer.
Chung MP; Margolis D; Mesko S; Wang J; Kupelian P; Kamrava M
J Med Imaging Radiat Oncol; 2014 Oct; 58(5):588-94. PubMed ID: 25196228
[TBL] [Abstract][Full Text] [Related]
13. Effect of Temporal Resolution on Diagnostic Performance of Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Prostate.
Othman AE; Falkner F; Weiss J; Kruck S; Grimm R; Martirosian P; Nikolaou K; Notohamiprodjo M
Invest Radiol; 2016 May; 51(5):290-6. PubMed ID: 26619282
[TBL] [Abstract][Full Text] [Related]
14. Correlation between dynamic contrast-enhanced MRI and quantitative histopathologic microvascular parameters in organ-confined prostate cancer.
van Niekerk CG; van der Laak JA; Hambrock T; Huisman HJ; Witjes JA; Barentsz JO; Hulsbergen-van de Kaa CA
Eur Radiol; 2014 Oct; 24(10):2597-605. PubMed ID: 25033819
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
16. Principal component analysis of dynamic contrast enhanced MRI in human prostate cancer.
Eyal E; Bloch BN; Rofsky NM; Furman-Haran E; Genega EM; Lenkinski RE; Degani H
Invest Radiol; 2010 Apr; 45(4):174-81. PubMed ID: 20177391
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of CAIPIRINHA-Dixon-TWIST-VIBE for dynamic contrast-enhanced MRI of the prostate.
Othman AE; Martirosian P; Schraml C; Taron J; Weiss J; Bier G; Schwentner C; Nickel D; Bamberg F; Kramer U; Nikolaou K; Notohamiprodjo M
Eur J Radiol; 2015 Nov; 84(11):2110-6. PubMed ID: 26321493
[TBL] [Abstract][Full Text] [Related]
18. Combined morphological, [1H]-MR spectroscopic and contrast-enhanced imaging of human prostate cancer with a 3-Tesla scanner: preliminary experience.
Carlani M; Mancino S; Bonanno E; Finazzi Agrò E; Simonetti G
Radiol Med; 2008 Aug; 113(5):670-88. PubMed ID: 18493829
[TBL] [Abstract][Full Text] [Related]
19. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters.
Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM
AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651
[TBL] [Abstract][Full Text] [Related]
20. Correlation between quantitative and semiquantitative parameters in DCE-MRI with a blood pool agent in rectal cancer: can semiquantitative parameters be used as a surrogate for quantitative parameters?
Dijkhoff RAP; Maas M; Martens MH; Papanikolaou N; Lambregts DMJ; Beets GL; Beets-Tan RGH
Abdom Radiol (NY); 2017 May; 42(5):1342-1349. PubMed ID: 28050622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
